Autopsy report · NCT03582956
Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes
Cause of deathStaffing, sites or logistics
“Covid”
Life of this trial
- Registered 7 months before it started.
- Ran for about 3 years 7 months before it stopped.
- 23 participants enrolled.
- Results were posted on the registry 1 year 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Yale University
- Sponsor type
- University, hospital or other
- Conditions
- Type1 Diabetes Mellitus; Adiposity
- Interventions
- Euglycemic hyperinsulinemic clamp with tracer enhancement; Euglycemic hyperinsulinemic clamp with tracer enhancement
- Participants
- 23
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.